INNOCRIN PHARMACEUTICALS HOLDINGS, LLC

Profile

Company Names

INNOCRIN PHARMACEUTICALS HOLDINGS, LLC

Addresses

4505 EMPEROR BOULEVARD, SUITE 240, DURHAM, NC 27703

4505 EMPEROR BOULEVARD, SUITE 300, DURHAM, NC 27703

Phone Numbers

919-237-9536
919-467-8539

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

PHARMACEUTICALS

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$42,100,001.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2017-07-11 
$6,000,000.00 
$13,000,000.00 
$7,000,000.00 
Debt 
2
2015-04-09 
$28,100,000.00 
$28,100,000.00 
$0.00 
Equity 
1
2014-11-26 
$8,000,001.00 
$14,000,001.00 
$6,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRED 
 
ESHELMAN 
EXECUTIVE OFFICER, DIRECTOR
XORI CORP   |  CORINTHIAN OPHTHALMIC, INC.   |  MERYX INC.   |  NEOANTIGENICS, INC.   |  DIGNIFY THERAPEUTICS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  ASEPTICYS, INC.   |  EYENOVIA, INC.   |  ASEPTICYS, LLC
RICHARD 
 
KENT 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  ALDAGEN INC   |  CSA MEDICAL INC   |  CYTOMEDIX INC   |  ESANEX, INC.   |  CEMPRA, INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  AVISTONE NORTH HIGHLANDS, LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  CSA MEDICAL, INC.   |  BARINGS GLOBAL CREDIT FUND (LUX) SCSP, SICAV-SIF   |  BARINGS REAL ESTATE EUROPEAN VALUE ADD FUND II, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  BARINGS EUROPEAN REAL ESTATE DEBT INCOME FUND, A SUB-FUND OF BARINGS UMBRELLA FUND (LUX) SCSP SICAV-RAIF   |  AVISTONE TULSA, LLC
THOMAS 
 
LAUNDON 
EXECUTIVE OFFICER
INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
WILLIAM 
 
MOORE 
EXECUTIVE OFFICER, DIRECTOR
HPA HOLDING CORP   |  ROOT WIRELESS, INC.   |  CASCADIA GROWERS ASSOCIATION LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  SHOAL GAMES LTD.   |  HUMAN, INC   |  XONA SYSTEMS, INC.   |  IRIDEX CORP
CHARLES 
 
OSBORNE 
EXECUTIVE OFFICER
GATEWAY FUND, L.P.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
DOUGLAS 
 
REED 
DIRECTOR
SPINEWORKS MEDICAL INC   |  SPINEALIGN MEDICAL INC   |  VIAMET PHARMACEUTICALS INC   |  PHASEBIO PHARMACEUTICALS INC   |  TETRALOGIC PHARMACEUTICALS CORP   |  HATTERAS VENTURE PARTNERS IV, LP   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  NEUROTRONIK, INC.   |  SIDERIS PHARMACEUTICALS, INC.   |  COFERON, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  BLINKBIO, INC.   |  HATTERAS VENTURE PARTNERS V, LP   |  QPEX BIOPHARMA, INC.   |  HATTERAS VENTURE PARTNERS VI, LP   |  EMX ROYALTY CORP   |  AVIVOMED INC.   |  HATTERAS VENTURE PARTNERS VII, LP   |  HATTERAS OPPORTUNITY FUND I, LP   |  HATTERAS CREATE SF SPV, LLC
JAMES 
 
ROSEN 
DIRECTOR
VIAMET PHARMACEUTICALS INC   |  ADVANCED ANIMAL DIAGNOSTICS INC   |  ARSENAL VASCULAR, INC.   |  ARSENAL MEDICAL, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  APPLIED GENETIC TECHNOLOGIES CORP   |  480 BIOMEDICAL, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  WAYBETTER, INC.
ROBERT 
 
SCHOTZINGER 
DIRECTOR
VIAMET PHARMACEUTICALS INC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  ELDEC PHARMACEUTICALS, INC.
S. 
EDWARD 
TORRES 
DIRECTOR
TRINITY BIOSYSTEMS INC   |  CYLENE PHARMACEUTICALS, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  COHERUS BIOSCIENCES, INC.   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
ANDREW 
 
VON ESCHENBACH 
DIRECTOR
VIAMET PHARMACEUTICALS INC   |  HISTOSONICS, INC.   |  VIAMET PHARMACEUTICALS HOLDINGS LLC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  CELULARITY INC.   |  COTA, INC.   |  TRISALUS LIFE SCIENCES, INC.
STEVEN 
 
WEINSTEIN 
DIRECTOR
BLACKWAVE INC.   |  SONITUS MEDICAL INC   |  SONITUS TECHNOLOGIES INC.   |  ADVANCED ANIMAL DIAGNOSTICS INC   |  INNOCRIN PHARMACEUTICALS HOLDINGS, LLC   |  GREGOR DIAGNOSTICS, INC.   |  PROPS2FANTASY.COM, INC.   |  SEISMIC CAPITAL CO   |  OCHOCO CAPITAL FUND, LP
KRISTOPHER 
 
WOOD 
DIRECTOR
INNOCRIN PHARMACEUTICALS HOLDINGS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-07-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2017-07-11 
2015-04-21
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-04-09 
2014-12-11
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-11-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#